Better outcomes were instead reported for the BCG-alone arm. Another Phase III ... Patients in the vaccine arm of the trial were shown to have worse outcomes than those in the control arm.

The tuberculosis vaccine, also known as the bacille Calmette-Guérin (BCG) vaccine, is used to protect against tuberculosis (TB) and related complications. The BCG vaccine is no longer routinely ...

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

The open-label, two-arm study will ... approval for BCG-unresponsive non-muscle invasive bladder cancer CIS, with or without papillary tumours. The AdHER2DC vaccine specifically targets the ...

New research adds to a growing body of evidence that Bacillus Calmette-Guerin (BCG), a vaccine for tuberculosis (TB), is associated to reduced possibility of contracting the Covid-19 virus.

A phase 2b trial has found that the vaccine has an overall protective efficacy of 50% three years after immunisation, an advance on the current BCG vaccine which is not very effective and ...

Jane Akinyi (right) holding her baby while a medic adminster a Bacillus Calmette–Guérin vaccine(BCG) vaccine at Forest Dispensary in Nakuru on January 28,2019.Most of the hospitals in the ...

On Monday, the BMC started the much-delayed pilot project to provide the anti-tuberculosis (TB) BCG vaccine to the high-risk adult population from 12 wards of the city. In the rest of the state ...